scholarly article | Q13442814 |
P50 | author | Juan Carlos Cardet | Q56930987 |
P2093 | author name string | Tao Liu | |
Anya J Cutler | |||
Chunli Feng | |||
Heng Chhay | |||
Joshua A Boyce | |||
Molly S Kidder | |||
Tanya M Laidlaw | |||
P2860 | cites work | Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes | Q24545573 |
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma | Q24564777 | ||
Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 | ||
Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors | Q24646354 | ||
Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma | Q28193250 | ||
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease | Q28193294 | ||
The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions | Q28193909 | ||
Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells | Q28194899 | ||
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management | Q28195986 | ||
Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma | Q28196323 | ||
Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge | Q28210320 | ||
PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease | Q28210926 | ||
Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand | Q28287399 | ||
gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen | Q28510583 | ||
The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. | Q34154301 | ||
Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma | Q35563238 | ||
Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation | Q36140425 | ||
Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions | Q36298336 | ||
Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia | Q36330659 | ||
Prostaglandin E receptors | Q36747756 | ||
Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation | Q37040964 | ||
Interaction of platelets and neutrophils in the generation of sulfidopeptide leukotrienes. | Q37054038 | ||
Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes | Q37240446 | ||
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. | Q37690942 | ||
Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses | Q41864224 | ||
Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase. | Q42809059 | ||
Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. | Q42826850 | ||
Cyclic AMP-independent activation of protein kinase A by vasoactive peptides | Q43594112 | ||
Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. | Q44072149 | ||
Recurrence of nasal polyps after surgical treatment. | Q44140828 | ||
Platelets are essential for leukocyte recruitment in allergic inflammation. | Q44504339 | ||
Tonic protein kinase A activity maintains inactive beta2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase. | Q44872711 | ||
Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma | Q46363432 | ||
Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. | Q46418233 | ||
The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction | Q46813273 | ||
Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge. | Q47885737 | ||
Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma | Q48020876 | ||
Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. | Q53619823 | ||
The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin | Q57240791 | ||
Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis | Q58411995 | ||
Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes | Q58412055 | ||
Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma | Q62520456 | ||
Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin | Q67257989 | ||
Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects | Q67915846 | ||
Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4 | Q69814383 | ||
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma | Q70906164 | ||
Expression of LTC4 synthase during the development of eosinophils in vitro from cord blood progenitors | Q71834809 | ||
Leukotriene C4 formation by transcellular biosynthesis | Q72029852 | ||
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics | Q74490010 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspirin | Q18216 |
prostaglandin E2 | Q416554 | ||
respiratory disease | Q3286546 | ||
P304 | page(s) | 1692-701.e3 | |
P577 | publication date | 2014-01-31 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease | |
P478 | volume | 133 |
Q36119388 | Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway |
Q40901391 | Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD). |
Q39175214 | Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease |
Q50025267 | Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms |
Q28079269 | Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New? |
Q30276354 | Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease |
Q64284781 | Evaluation of Neutrophil Activation Status According to the Phenotypes of Adult Asthma |
Q30407185 | Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis |
Q30279219 | Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. |
Q38738551 | International Consensus Statement on Allergy and Rhinology: Rhinosinusitis |
Q55192190 | Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines. |
Q99575721 | Lipid-mediated innate lymphoid cell recruitment and activation in AERD |
Q64912616 | Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease. |
Q26779940 | Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma |
Q28080840 | Platelets in patients with aspirin-exacerbated respiratory disease |
Q36782772 | Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease |
Search more.